Age, gender, and lifestyle are key factors in predicting risks for illnesses like cancer and heart disease, but adding race ...

Classic game-day advertisers like Hellmann's Mayo, Stella Artois, Bud Light and Pringles are revealing the A-list stars ...

On January 27, 2025, iCAD, Inc. (NASDAQ: ICAD) disclosed certain preliminary, unaudited financial information for the fourth quarter ending on December 31, 2024, alongside additional corporate ...

Advances in artificial intelligence (AI) are revolutionizing cancer detection and care. Researchers now report that AI tools ...

Pathologists supported by a new artificial intelligence tool outperformed Standard of Care/Gold standard in determining ...

Artificial intelligence (AI) is able to identify women who have an elevated risk of developing breast cancer several years ...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed.

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

As GenAI tools and SaaS platforms become a staple component in the employee toolkit, the risks associated with data exposure, ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.